Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH3A1 | P30838 | 10/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5820103 | 1.00 | ALDH3A1 (0.58) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL5819897 | 0.90 | CA1 (0.55) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL5819895 | 0.90 | CA1 (0.55) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL5821735 | 0.83 | CA1 (0.45) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL5821740 | 0.82 | CA1 (0.41) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL5821742 | 0.82 | CA1 (0.41) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL4575601 | 0.82 | KDR (0.60) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| SCHEMBL4575597 | 0.82 | KDR (0.60) | ALDH3A1ALDH1A1CA1CA2BCHE | |
| Methylpiperazine SCHEMBL6424762 | 0.78 | KDR (0.55) | ALDH3A1ALDH1A1CA1CA2 | |
| Methylpiperazine SCHEMBL6424765 | 0.78 | KDR (0.55) | ALDH3A1ALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006105795-A1 | NOVEL INDOLINONE DERIVATIVES | LEO PHARMA A/S (DK) | 2006-10-12 | — | — | WO | disclosed |